ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2023

Zinzino group revenue increased with a total of 24%, compared with the previous year.

 

The revenue in February for Zinzino's sales markets increased by 23 % and amounted to SEK 109.6 (89.0) million. Faun Pharma's external sales increased by 34 % and amounted to SEK 8.7 (6.5) million. Overall, the Group increased revenues by 24 % to SEK 118.3 (95.5) million compared with the previous year.

Accumulated revenue for January – February 2023 increased by 21% to SEK 247.7 (204.5) million.

Revenues were distributed as follows:

Regions,MSEK	23-Feb	22-Feb	Change	YTD 2023	YTD 2022	Change
The Nordics	23.2	21.5	8%	46.7	47.5	-2%
Central Europe	26.9	18.5	45%	55.4	36.9	50%
East Europe	25.2	23.3	8%	58.0	52.0	12%
South & West Europe	14.4	11.2	29%	30.3	23.3	30%
The Baltics	6.0	5.2	15%	13.4	11.6	16%
North America	6.5	4.3	51%	12.8	8.7	47%
Asia-Pacific	6.4	4.6	39%	10.9	10.3	6%
Africa	1.0	0.4	150%	2.4	0.8	200%
Zinzino	109.6	89.0	23%	229.9	191.1	20%
Faun Pharma	8.7	6.5	34%	17.8	13.4	33%
Zinzino Group	118.3	95.5	24%	247.7	204.5	21%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:

marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se